Malignant melanoma is the third most common skin cancer yet has the highest mortality rate due to its predilection for metastasis. While the diagnosis of antemortem melanoma with cardiac metastasis is relatively uncommon, diagnosing malignant melanoma itself by first identifying a cardiac metastasis is even more rare. This vignette describes an antemortem diagnosis of melanoma in a 50-year-old woman through identification of metastasis to multiple sites, including the tricuspid valve. I n the US, skin cancer has the highest prevalence of any cancer ( 1 ). It is the most common type of cancer found in young women, with approximately 1 in 50 developing the disease within their lifetime ( 2 ). Th e median survival for patients with metastatic melanoma is just a few months ( 3 ).
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CASE REPORT
A 50-year-old white woman presented with back pain during yoga. She endorsed lower extremity numbness and weakness, intermittent visual auras, handwriting changes, dyspnea on exertion, fever, fatigue, and a 10-pound weight loss of 2 months' duration. She had been very active and recently stopped daily cardiovascular workouts in favor of yoga. On presentation she needed a cane to walk. She had a history of hypertension, hypothyroidism, and asthma. Her medications included levothyroxine, metoprolol succinate, montelukast, and an albuterol rescue inhaler. Physical examination disclosed an extra diastolic heart sound over the left fi fth intercostal space. She had diminished sensation to fi ne touch distal to the left knee, reduced hip fl exion, and marked weakness bilaterally with quadriceps extension, knee fl exion, plantar extension, and fl exion. She had no lesions in the skin or mucous membranes. Magnetic resonance imaging (MRI) of the brain and spine revealed a mass on the conus medullaris and multiple intraparenchymal lesions in the cerebral hemispheres bilaterally. Computed tomography (CT) of the chest, abdomen, and pelvis performed for staging purposes demonstrated an intracardiac mass (Figure) . Transthoracic echocardiogram disclosed a 5.3 × 3.2 cm right atrial mass that prolapsed into the right ventricle during ventricular systole (video; see link at https://youtu.be/RIf8JNKl0po ). CT of the chest revealed a soft tissue density in the subcutaneous fat of the chest, a biopsy of which showed melanoma. Th e melanoma 
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Charis G. Durham , MD, James A. Hall , DO, Erica J. Fidone , MD, Ryan Mack , MD, and Austin L. Metting, MD was BRAF positive, and vemurafenib was started along with radiation of the spine and brain. Th e size of the cardiac and cerebral masses 6 months later had decreased. However, the patient ultimately stopped therapy due to progression of disease and subsequently initiated hospice care.
DISCUSSION
A study that reviewed autopsies in 70 patients with melanoma demonstrated that cardiac metastases occurred in up to 65% of the cases ( 4 ). Although cardiac melanoma metastasis is not uncommon, a diagnosis of antemortem cardiac metastasis is unusual and has been described in <10% of melanoma cases ( 5 ) .
Once metastasized to other organs, melanoma is by defi nition stage IV with poor survival rates; the 5-year survival is 15% to 20% ( 6 ). Currently, gold standard diagnostic imaging is positron emission tomography-computed tomography ( 7 ), which can be used concomitantly with MRI of the brain and CT of the chest, abdomen, and pelvis. One of the reasons that cardiac metastasis is so easily undiagnosed is that patients remain free of cardiac symptoms ( 8 ) . Of the imaging modalities employed to identify cardiac masses, cardiac MRI has demonstrated the best utility ( 9 ) . BRAF gene mutations are found in half of melanoma cases; therefore, all patients diagnosed with metastatic melanoma should be evaluated for a V600 BRAF mutation. Vemurafenib is a selective BRAF inhibitor that has led to a positive response in >60% of cases, as demonstrated by regression in tumor size, longer survival (13.6 months vs. 9.7 months with dacarbazine), and a median response time period of 5 months ( 10 ).
Our case is unique not only because cardiac metastasis was found at the time melanoma was diagnosed, but also because a primary was never found, which is a rare occurrence ( 11 , 12 ) .
